February 4: The Week in Cancer News
CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.
Progress Against Cancer
CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), along with other...
A new kind of blood test could help detect brain tumors at an earlier stage.
Pharmacies asked to stop turning immune-compromised people away for fourth shot, and fiber intake is associated with stronger immune...
Metastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are...
Cancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients...
Study investigates factors that contribute to cancer outcomes in a large and growing segment of the U.S. population.
Women with breast cancer who choose fertility preservation have treatment outcomes similar to women who don’t undergo fertility preservation.
Researchers aim to minimize disease relapses by targeting multiple proteins.
Three out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit...